Alexandra Flemming
Alexandra Flemming is a German biologist, academic, and the editor in chief of Nature Reviews Immunology.
Education[edit]
Flemming studied molecular biology at the University of Freiburg before moving to South Africa to study infectious immunology at the University of Cape Town.[1]
She obtained her PhD at the University of Freiburg's Max-Planck Institute for Immunology and won awards for her thesis about the role of the B cell signaling protein SLP‑65 in the malignant transformation of B cells.[1] She continued studying as a European Molecular Biology Organization fellow and as a Human Frontiers Science Programme fellow, seconded to Cancer Research UK in London.[1]
Career[edit]
Flemming is employed in the department of molecular immunology in the faculty of biology at the University of Freiburg.[2]
She joined Nature Reviews Drug Discovery as an associate editor before becoming the editor in chief of Nature Reviews Immunology in 2017.[1]
References[edit]
- ^ a b c d "About the Editors | Nature Reviews Immunology". www.nature.com. Retrieved 2022-04-05.
- ^ "Alexandra Flemming - profile". www.aminer.org. Retrieved 2022-04-05.